help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, Y.-k.
Right arrow Articles by Gantz, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, Y.-k.
Right arrow Articles by Gantz, I.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*Structure*UniGene
*Compound via MeSH
*Substance via MeSH
Molecular Endocrinology 13 (1): 148-155
Copyright © 1999 by The Endocrine Society

Characterization of Agouti-Related Protein Binding to Melanocortin Receptors

Ying-kui Yang, Darren A. Thompson, Chris J. Dickinson, Jill Wilken, Greg S. Barsh, Stephen B. H. Kent and Ira Gantz

Departments of Surgery (Y-k.Y., I.G.) and Pediatrics (C.J.D.) University of Michigan Medical Center Ann Arbor, Michigan 48109-0682
Howard Hughes Medical Institute (G.S.B.) Stanford University School of Medicine Stanford, California 94305 Gryphon Sciences (D.A.T., J.W., S.B.H.K.), South San Francisco, California 94080

Agouti-related protein (AGRP) is a naturally occurring antagonist of melanocortin action that is thought to play an important role in the hypothalamic control of feeding behavior. The exact mechanism of AGRP and Agouti protein action has been difficult to examine, in part because of difficulties in producing homogeneous forms of these molecules that can be used for direct binding assays. In this report we describe the application of chemical protein synthesis to the construction of two novel AGRP variants. Examination of the biological activity of the AGRP variants demonstrates that a truncated variant, human AGRP(87–132), a 46-amino acid variant based on the carboxyl-terminal cysteine-rich domain of AGRP, is equipotent to an 111-amino acid variant, mouse [Leu127Pro]AGRP (mature AGRP minus its signal sequence), in its ability to dose dependently inhibit {alpha}-MSH-generated cAMP generation at the cloned melanocortin receptors. Furthermore, deletion of the amino-terminal portion of the full-length variant did not alter the MCR subtype specificity of AGRP(87–132). Finally, iodination of human AGRP(87–132) provided a useful reagent with which the binding properties of AGRP could be analyzed. In both conventional and photoemulsion binding studies [125I]AGRP(87–132) was observed only to bind to cells expressing melanocortin receptors MC3R, MC4R, and MC5R. These results demonstrate that the residues critical for receptor binding, {alpha}-MSH inhibition, and melanocortin receptor subtype specificity are all located in the carboxyl terminus of the molecule. Because [Nle4, D-Phe7] (NDP)-MSH displaces the binding of [125I]AGRP(87–132) to MCRs and AGRP(87–132) displaces the binding of [125I]NDP-MSH, we conclude that these molecules bind in a competitive fashion to melanocortin receptors.




This article has been cited by other articles:


Home page
 GeneticsHome page
N. J. Nadeau, F. Minvielle, S. Ito, M. Inoue-Murayama, D. Gourichon, S. A. Follett, T. Burke, and N. I. Mundy
Characterization of Japanese Quail yellow as a Genomic Deletion Upstream of the Avian Homolog of the Mammalian ASIP (agouti) Gene
Genetics, February 1, 2008; 178(2): 777 - 786.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Chen, M. Cai, C. J. Aprahamian, K. E. Georgeson, V. Hruby, C. M. Harmon, and Y. Yang
Contribution of the Conserved Amino Acids of the Melanocortin-4 Receptor in D-[Nle4,Phe7]-{alpha}-Melanocyte-stimulating Hormone Binding and Signaling
J. Biol. Chem., July 27, 2007; 282(30): 21712 - 21719.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
M. A. Smith, K. Hisadome, H. Al-Qassab, H. Heffron, D. J. Withers, and M. L. J. Ashford
Melanocortins and agouti-related protein modulate the excitability of two arcuate nucleus neuron populations by alteration of resting potassium conductances
J. Physiol., January 15, 2007; 578(2): 425 - 438.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Aja, S. Bi, S. B. Knipp, J. M. McFadden, G. V. Ronnett, F. P. Kuhajda, and T. H. Moran
Intracerebroventricular C75 decreases meal frequency and reduces AgRP gene expression in rats
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R148 - R154.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. W. M. Creemers, L. E. Pritchard, A. Gyte, P. Le Rouzic, S. Meulemans, S. L. Wardlaw, X. Zhu, D. F. Steiner, N. Davies, D. Armstrong, et al.
Agouti-Related Protein Is Posttranslationally Cleaved by Proprotein Convertase 1 to Generate Agouti-Related Protein (AGRP)83-132: Interaction between AGRP83-132 and Melanocortin Receptors Cannot Be Influenced by Syndecan-3
Endocrinology, April 1, 2006; 147(4): 1621 - 1631.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
W. Pan, A. J. Kastin, Y. Yu, C. M. Cain, T. Fairburn, A. M. Stutz, C. Morrison, and G. Argyropoulos
Selective Tissue Uptake of Agouti-Related Protein(82-131) and Its Modulation by Fasting
Endocrinology, December 1, 2005; 146(12): 5533 - 5539.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
L. S. Tallam, J. J. Kuo, A. A. da Silva, and J. E. Hall
Cardiovascular, Renal, and Metabolic Responses to Chronic Central Administration of Agouti-Related Peptide
Hypertension, December 1, 2004; 44(6): 853 - 858.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. Huo, H. Munzberg, E. A. Nillni, and C. Bjorbaek
Role of Signal Transducer and Activator of Transcription 3 in Regulation of Hypothalamic trh Gene Expression by Leptin
Endocrinology, May 1, 2004; 145(5): 2516 - 2523.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Doghman, P. Delagrange, A. Blondet, M.-C. Berthelon, P. Durand, D. Naville, and M. Begeot
Agouti-Related Protein Antagonizes Glucocorticoid Production Induced through Melanocortin 4 Receptor Activation in Bovine Adrenal Cells: A Possible Autocrine Control
Endocrinology, February 1, 2004; 145(2): 541 - 547.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
Y. Yang, M. Chen, Y. Lai, I. Gantz, A. Yagmurlu, K. E. Georgeson, and C. M. Harmon
Molecular Determination of Agouti-Related Protein Binding to Human Melanocortin-4 Receptor
Mol. Pharmacol., July 1, 2003; 64(1): 94 - 103.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
W. A. J. Nijenhuis, K. M. Garner, R. J. van Rozen, and R. A. H. Adan
Poor Cell Surface Expression of Human Melanocortin-4 Receptor Mutations Associated with Obesity
J. Biol. Chem., June 13, 2003; 278(25): 22939 - 22945.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
G. S.H. Yeo, E. J. Lank, I. S. Farooqi, J. Keogh, B. G. Challis, and S. O'Rahilly
Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms
Hum. Mol. Genet., March 1, 2003; 12(5): 561 - 574.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. A. Nickolls, M. I. Cismowski, X. Wang, M. Wolff, P. J. Conlon, and R. A. Maki
Molecular Determinants of Melanocortin 4 Receptor Ligand Binding and MC4/MC3 Receptor Selectivity
J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1217 - 1227.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. Zheng, M. M. Corkern, S. M. Crousillac, L. M. Patterson, C. B. Phifer, and H.-R. Berthoud
Neurochemical phenotype of hypothalamic neurons showing Fos expression 23 h after intracranial AgRP
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1773 - R1781.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Y.-K. Yang, C. Dickinson, Y.-M. Lai, J.-Y. Li, and I. Gantz
Functional properties of an agouti signaling protein variant and characteristics of its cognate radioligand
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2001; 281(6): R1877 - R1886.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. M. Lechan and J. B. Tatro
Editorial: Hypothalamic Melanocortin Signaling in Cachexia
Endocrinology, August 1, 2001; 142(8): 3288 - 3291.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. J. Hwa, L. Ghibaudi, J. Gao, and E. M. Parker
Central melanocortin system modulates energy intake and expenditure of obese and lean Zucker rats
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R444 - R451.
[Abstract] [Full Text] [PDF]

Home page
 GeneticsHome page
T. M. Gunn, T. Inui, K. Kitada, S. Ito, K. Wakamatsu, L. He, D. M. Bouley, T. Serikawa, and G. S. Barsh
Molecular and Phenotypic Analysis of Attractin Mutant Mice
Genetics, August 1, 2001; 158(4): 1683 - 1695.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. H. Hani, S. Dupont, E. Durand, C. Dina, S. Gallina, I. Gantz, and P. Froguel
Naturally Occurring Mutations in the Melanocortin Receptor 3 Gene Are Not Associated with Type 2 Diabetes Mellitus in French Caucasians
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2895 - 2898.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Katsuki, Y. Sumida, E. C. Gabazza, S. Murashima, T. Tanaka, M. Furuta, R. Araki-Sasaki, Y. Hori, K. Nakatani, Y. Yano, et al.
Plasma Levels of Agouti-Related Protein Are Increased in Obese Men
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1921 - 1924.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
W. A. J. Nijenhuis, J. Oosterom, and R. A. H. Adan
AgRP(83-132) Acts as an Inverse Agonist on the Human-Melanocortin-4 Receptor
Mol. Endocrinol., January 1, 2001; 15(1): 164 - 171.
[Abstract] [Full Text]

Home page
 Physiol. Rev.Home page
A. Slominski, J. Wortsman, T. Luger, R. Paus, and S. Solomon
Corticotropin Releasing Hormone and Proopiomelanocortin Involvement in the Cutaneous Response to Stress
Physiol Rev, July 1, 2000; 80(3): 979 - 1020.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. M. Hagan, P. A. Rushing, L. M. Pritchard, M. W. Schwartz, A. M. Strack, L. H. T. Van der Ploeg, S. C. Woods, and R. J. Seeley
Long-term orexigenic effects of AgRP-(83---132) involve mechanisms other than melanocortin receptor blockade
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2000; 279(1): R47 - R52.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J.-Y. Li, S. Finniss, Y.-K. Yang, Q. Zeng, S.-Y. Qu, G. Barsh, C. Dickinson, and I. Gantz
Agouti-Related Protein-Like Immunoreactivity: Characterization of Release from Hypothalamic Tissue and Presence in Serum
Endocrinology, June 1, 2000; 141(6): 1942 - 1950.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. M. Dinulescu and R. D. Cone
Agouti and Agouti-related Protein: Analogies and Contrasts
J. Biol. Chem., March 15, 2000; 275(10): 6695 - 6698.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
A. Inui
Transgenic Approach to the Study of Body Weight Regulation
Pharmacol. Rev., March 1, 2000; 52(1): 35 - 62.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y.-k. Yang, C. J. Dickinson, Q. Zeng, J.-Y. Li, D. A. Thompson, and I. Gantz
Contribution of Melanocortin Receptor Exoloops to Agouti-related Protein Binding
J. Biol. Chem., May 14, 1999; 274(20): 14100 - 14106.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Oosterom, K. M. Garner, W. K. den Dekker, W. A. J. Nijenhuis, W. H. Gispen, J. P. H. Burbach, G. S. Barsh, and R. A. H. Adan
Common Requirements for Melanocortin-4 Receptor Selectivity of Structurally Unrelated Melanocortin Agonist and Endogenous Antagonist, Agouti Protein
J. Biol. Chem., January 5, 2001; 276(2): 931 - 936.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society